Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 327

LightCyber detects Access for $20m round

Access Industries' Israel-based subsidiary co-led cyberthreat detection software provider LightCyber's latest round, taking its overall funding to more than $31m.

Jun 23, 2016

Novartis spells out series A support for IFM

Novartis has supplied cash to IFM Therapeutics' $27m series A round to help the biopharmaceutical company's efforts to develop a cancer treatment.

Jun 23, 2016

Legend Holdings tunes into Kaola FM

Kaolo FM, a network operated by AutoRadio Group, has raised $26m in a round featuring Legend's corporate venturing unit.

Jun 22, 2016

Ant Financial looks to Ascend

Alibaba's financial services affiliate is set to take a 20% stake in Thailand-based Ascend Money, shortly after investing $35m in Shanghai Suntime Information Technology.

Jun 21, 2016

Andela recruits GV for $24m series B

The Alphabet subsidiary has taken part in a round for Andela, which recruits Africa-based programmers on behalf of US tech companies.

Jun 20, 2016

SI-Bone connects to $20m

Novo-backed SI-Bone has added $20m to its coffers in a funding round led by Arboretum Ventures that featured all its major existing shareholders.

Jun 20, 2016

Mersana flexes for $33m

Takeda, which formed a strategic partnership agreement with Mersana in February, has taken part in a series C round to help the company expand its Fleximer platform.

Jun 20, 2016

Collective Media assembles $34m in investment

The adtech company, backed by Cox Media and Samsung, has increased its total funding by $34m to support further development of its enterprise advertising hub.

Jun 17, 2016

Rgenix generates $33m in series B round

Novo and Sofinnova Partners have co-led a series B round for Rgenix, a spinout of Rockefeller University that hopes to enter two immunotherapies into clinical trials this autumn.

Jun 16, 2016

Rgenix generates $33m in series B round

Novo and Sofinnova Partners have co-led a series B round for Rgenix, which is preparing to enter two immunotherapies into clinical trials this autumn.

Jun 16, 2016
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here